Research progress in the treatment of small cell lung cancer.
about
#2714, a novel active inhibitor with potent G2/M phase arrest and antitumor efficacy in preclinical models.3′-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells.Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer.
P2860
Research progress in the treatment of small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Research progress in the treatment of small cell lung cancer.
@en
Research progress in the treatment of small cell lung cancer.
@nl
type
label
Research progress in the treatment of small cell lung cancer.
@en
Research progress in the treatment of small cell lung cancer.
@nl
prefLabel
Research progress in the treatment of small cell lung cancer.
@en
Research progress in the treatment of small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Research progress in the treatment of small cell lung cancer.
@en
P2093
Wei-Zhi Tang
Wen-Juan Yang
Yan-Fang Qiu
Zhi-Gang Liu
P2860
P356
10.7150/JCA.16822
P577
2017-01-01T00:00:00Z